{"id":"https://openalex.org/W4361237981","doi":"https://doi.org/10.1158/0008-5472.c.6508437.v1","title":"Data from Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes","display_name":"Data from Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361237981","doi":"https://doi.org/10.1158/0008-5472.c.6508437.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6508437.v1","doi":"https://doi.org/10.1158/0008-5472.c.6508437.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6508437.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6508437.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009118439","display_name":"Andriy Marusyk","orcid":"https://orcid.org/0000-0002-0087-9575","observed_orcids":["https://orcid.org/0000-0002-0087-9575"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andriy Marusyk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027282129","display_name":"Doris P. Tabassum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Doris P. Tabassum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062665576","display_name":"Michalina Janiszewska","orcid":"https://orcid.org/0000-0002-8592-5146","observed_orcids":["https://orcid.org/0000-0002-8592-5146"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michalina Janiszewska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036283202","display_name":"Andrew E. Place","orcid":"https://orcid.org/0000-0002-9604-4213","observed_orcids":["https://orcid.org/0000-0002-9604-4213"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew E. Place","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029917436","display_name":"Anne C. Trinh","orcid":"https://orcid.org/0000-0001-7261-6734","observed_orcids":["https://orcid.org/0000-0001-7261-6734"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Trinh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088298276","display_name":"Andrii I. Rozhok","orcid":"https://orcid.org/0000-0002-9475-0472","observed_orcids":["https://orcid.org/0000-0002-9475-0472"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrii I. Rozhok","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044355098","display_name":"Saumyadipta Pyne","orcid":"https://orcid.org/0000-0003-3470-2345","observed_orcids":["https://orcid.org/0000-0003-3470-2345"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saumyadipta Pyne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108281148","display_name":"Jennifer L. Guerriero","orcid":"https://orcid.org/0000-0002-2104-5457","observed_orcids":["https://orcid.org/0000-0002-2104-5457"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer L. Guerriero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003496062","display_name":"Shaokun Shu","orcid":"https://orcid.org/0000-0001-6839-2782","observed_orcids":["https://orcid.org/0000-0001-6839-2782"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shaokun Shu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054827381","display_name":"Muhammad B. Ekram","orcid":"https://orcid.org/0000-0001-5555-6872","observed_orcids":["https://orcid.org/0000-0001-5555-6872"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muhammad Ekram","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002565739","display_name":"Alexander Ishkin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Ishkin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014614164","display_name":"Daniel P. Cahill","orcid":"https://orcid.org/0000-0003-2552-6546","observed_orcids":["https://orcid.org/0000-0003-2552-6546"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel P. Cahill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070287780","display_name":"Yuri Nikolsky","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuri Nikolsky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080223712","display_name":"Timothy An-thy Chan","orcid":"https://orcid.org/0000-0002-9265-0283","observed_orcids":["https://orcid.org/0000-0002-9265-0283"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy A. Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072850149","display_name":"Mothaffar Fahed Rimawi","orcid":"https://orcid.org/0000-0002-4284-5656","observed_orcids":["https://orcid.org/0000-0002-4284-5656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mothaffar F. Rimawi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073398031","display_name":"Susan Galloway Hilsenbeck","orcid":"https://orcid.org/0000-0002-7962-673X","observed_orcids":["https://orcid.org/0000-0002-7962-673X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan Hilsenbeck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030115311","display_name":"Rachel Schiff","orcid":"https://orcid.org/0000-0003-1696-5213","observed_orcids":["https://orcid.org/0000-0003-1696-5213"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Schiff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037774999","display_name":"Charles Kent Osborne","orcid":"https://orcid.org/0000-0002-0044-618X","observed_orcids":["https://orcid.org/0000-0002-0044-618X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kent C. Osborne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112258237","display_name":"Antony Letai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antony Letai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014395742","display_name":"Korn\u00e9lia Poly\u00e1k","orcid":"https://orcid.org/0000-0002-5964-0382","observed_orcids":["https://orcid.org/0000-0002-5964-0382"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kornelia Polyak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.7157999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.7157999873161316,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.11980000138282776,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0835999995470047,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-associated-fibroblasts","display_name":"cancer-associated fibroblasts","score":0.9039999842643738},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9290000200271606},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6859999895095825},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.6899999976158142},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9549999833106995},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.7250000238418579},{"id":"https://openalex.org/keywords/jak2-stat3-signaling-pathway","display_name":"JAK2/STAT3 signaling","score":0.9100000262260437},{"id":"https://openalex.org/keywords/hyaluronic-acid","display_name":"hyaluronic acid","score":0.9909999966621399},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8700000047683716},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.3930000066757202},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.5669999718666077},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/gene-expression-signatures","display_name":"gene expression signatures","score":0.597000002861023},{"id":"https://openalex.org/keywords/spatial-proximity","display_name":"spatial proximity","score":0.4129999876022339}],"concepts":[{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.8203750252723694},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7285146713256836},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.653448760509491},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.56902676820755},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5430073738098145},{"id":"https://openalex.org/C2909706936","wikidata":"https://www.wikidata.org/wiki/Q42417562","display_name":"Cancer-Associated Fibroblasts","level":4,"score":0.541039228439331},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.536254346370697},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.491565078496933},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44196322560310364},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2700542211532593},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.16907310485839844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6508437.v1","doi":"https://doi.org/10.1158/0008-5472.c.6508437.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6508437.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6508437.v1","doi":"https://doi.org/10.1158/0008-5472.c.6508437.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6508437.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4312823718","https://openalex.org/W2362034133","https://openalex.org/W2158770220","https://openalex.org/W2256616461","https://openalex.org/W4200547365","https://openalex.org/W4386836027","https://openalex.org/W3096600782","https://openalex.org/W4313339714","https://openalex.org/W3205593170","https://openalex.org/W3006386809"],"abstract_inverted_index":{"Abstract":[0],"Using":[1,84],"a":[2,121,129],"three-dimensional":[3],"coculture":[4],"model,":[5],"we":[6,88],"identified":[7,89],"significant":[8,122],"subtype-specific":[9],"changes":[10,152],"in":[11,23,39,57,102,105,115,131,153],"gene":[12,30],"expression,":[13],"metabolic,":[14],"and":[15,36,60,70,104,109,128,149,156],"therapeutic":[16,142,163],"sensitivity":[17],"profiles":[18],"of":[19,73,76,124,135],"breast":[20,68,77,96,117],"cancer":[21,78,97,126,154],"cells":[22,49,59,98,127,138,155],"contact":[24],"with":[25],"cancer-associated":[26],"fibroblasts":[27,45],"(CAF).":[28],"CAF-induced":[29,147],"expression":[31],"signatures":[32],"predicted":[33],"clinical":[34],"outcome":[35],"immune-related":[37],"differences":[38],"the":[40,132],"microenvironment.":[41],"We":[42],"found":[43],"that":[44],"strongly":[46],"protect":[47],"carcinoma":[48,58],"from":[50,66],"lapatinib,":[51],"attributable":[52],"to":[53,99,120,139],"its":[54],"reduced":[55],"accumulation":[56],"an":[61],"elevated":[62],"apoptotic":[63],"threshold.":[64],"Fibroblasts":[65],"normal":[67],"tissues":[69],"stromal":[71],"cultures":[72],"brain":[74],"metastases":[75],"had":[79],"similar":[80],"effects":[81],"as":[82],"CAFs.":[83],"synthetic":[85],"lethality":[86],"approaches,":[87],"molecular":[90],"pathways":[91],"whose":[92],"inhibition":[93],"sensitizes":[94],"HER2+":[95,116],"lapatinib":[100,113],"both":[101],"vitro":[103],"vivo,":[106],"including":[107],"JAK2/STAT3":[108],"hyaluronic":[110],"acid.":[111],"Neoadjuvant":[112],"therapy":[114],"tumors":[118],"lead":[119],"increase":[123],"phospho-STAT3+":[125],"decrease":[130],"spatial":[133],"proximity":[134],"proliferating":[136],"(Ki67+)":[137],"CAFs":[140],"impacting":[141],"responses.":[143],"Our":[144],"studies":[145],"identify":[146],"physiologically":[148],"clinically":[150],"relevant":[151],"offer":[157],"novel":[158],"approaches":[159],"for":[160],"overcoming":[161],"microenvironment-mediated":[162],"resistance.":[164],"Cancer":[165],"Res;":[166],"76(22);":[167],"6495\u2013506.":[168],"\u00a92016":[169],"AACR.":[170]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}